Papers
1
Total Citations
3
H-Index
1
About
Dr. Wenbo Shu is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for esophageal cancer. His major contributions lie in rigorously comparing the short-term outcomes of robot-assisted esophagectomy (RAE), video-assisted minimally invasive esophagectomy (VAMIE), and traditional open esophagectomy (OE). In his most cited 2024 retrospective study, Dr. Shu provided critical evidence on the efficacy and safety of these approaches following neoadjuvant treatment, helping to clarify which surgical modality offers the best balance of oncologic control and recovery for resectable esophageal cancer. This work has already garnered 3 citations, signaling its growing influence in the field. By systematically evaluating these techniques, Dr. Shu is shaping clinical decision-making and guiding surgeons toward more personalized, less invasive options. His research is particularly valuable for students and clinicians seeking to understand the real-world trade-offs between robotic, video-assisted, and open surgery in complex oncologic cases. Dr. Shu’s dedication to evidence-based surgical innovation continues to drive improvements in patient outcomes and postoperative quality of life.
Research Focus
Key Achievements
Top Papers
- 1